These GSNOR knock out mice have been demonstrated to have a propensity for the development of hepatic tumors, while human hepatocellular carcinoma patients have diminished GSNOR activity and expanded SNO protein pools [192]. This evidence concerns the gene ADH5 and hepatocellular carcinoma.